News & Events
March is Social Work Month
Astera social workers are an integral part of our multidisciplinary team.
Read More
The Importance of Organ Donation
Today is National Donor Day. Today we celebrate those who are organ donors, and we think of those waiting to receive organs that may save their life.
Read More
Heart Disease & Cancer May Share Risk Factors
Heart disease and cancer are two of the leading causes of death worldwide. During American Heart Month, raising awareness about the connection between these two conditions and the steps people can take to reduce their risk is important.
Read More
The Power of Philanthropy in Cancer Care
Renowned medical oncologist Michael J. Nissenblatt, MD, is one of Astera Cancer Care’s founders.
Read More
Providing Innovative Cancer Care: Expanding Episodes of Care
When someone is diagnosed with cancer, their whole life changes, they must discuss treatment options with their doctor, among the first things they must do.
Read More
Research and Clinical Trials
Astera started its research program in November 2019. In the beginning, their team had one dedicated staff member, Percy Yeung, with two clinical trials. However, under Dr. Bruno Fang’s guidance and support from our providers and clinic staff, we are now offering over 25 clinical trials to our patients with four dedicated staff members.
Read More
Treating the breast and sparing the heart
Breast cancer survival has steadily increased due to earlier detection, decreasing morbidity from surgery, more effective therapies, and advances in radiation delivery.
Read More
Social Work
Social work helps patients and their families cope with cancer and its many challenges by providing concrete or supportive services.
Read More
The Benefits of Radiation Therapy for Skin Cancer
Radiation therapy is a highly-effective, non-surgical treatment option for both basal cell and squamous cell carcinomas.
Read More
Prostate SBRT in 5 Fractions
Stereotactic Body Radiotherapy (SBRT) is an emerging treatment modality with excellent control rates for low and intermediate-risk prostate cancer. It is a precise, high-dose form of radiation therapy that allows physicians to treat cancer in just one to five treatments.
Read More